PCI Biotech Holding ASA (PCIB) — Cash Flow Quality Index

Latest as of March 2020: -5.17x

PCI Biotech Holding ASA (PCIB) has a Cash Flow Quality Index of -5.17x as of March 2020. Operating cash flow of Nkr-22.87 Million is below net income of Nkr4.43 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PCI Biotech Holding ASA (PCIB) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-5.17x

Operating CF / Net Income

Operating Cash Flow

Nkr-22.87 Million

NOK

Net Income

Nkr4.43 Million

NOK

Data as of

Mar 2020

Most recent filing

Annual Cash Flow Quality Index for PCI Biotech Holding ASA (None–None)

Year-by-year earnings quality comparison for PCI Biotech Holding ASA. For live market cap and the full company financial profile, see PCIB stock market capitalisation.

Year	Quality Index	Operating CF (NOK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.